This technology is a blockchain solution for the harmonized integration of clinical and biological data used in personalized medicine.
Enabling effective and scalable precision medicine requires a framework capable of integrating and sharing clinical and genetic data in a secure manner. Current approaches employ systems that lack the ability to effectively handle the unique nature of these datasets due to the complexities associated with privacy and data ownership.
This technology depicts a secure and efficient blockchain system to store clinical and genetic data. Blockchain is a cryptographic platform that can facilitate the multimodal process of recording, tracking, and sharing data in a decentralized fashion. As such, a blockchain solution can be used to generate specific cohorts of data based on clinical and biological characteristics to study relationships and outcomes. Moreover, this technology allows patients and institutions secure control over their data and its usage.
This technology has been validated in datasets from patients with Amyotrophic Lateral Sclerosis (ALS).
Patent pending
IR CU23145
Licensing Contact: Sara Gusik